About AFPT - Club Phase 1 webinar: First-In-Human Dose Selection & Approaches
AFPT - Club Phase 1 webinar: First-In-Human Dose Selection & Approaches
To start the clinical development, the first-in-human dose selection including the starting dose and the dose range is a key step for a successful clinical drug development with small molecules or biologics. There is no unique approach.
Save the date: June 19th (3:00-4:00 pm CET/ 9:00-10:00 am EDT) to review the different approaches with a subject matter expert.
A separate webinar on September 23rd, 2024 will focus especially on the dose optimization in oncology.
___________________________________________________________________________
Become a member of the AFPT - Club Phase 1 association to benefit freely from the 2024 webinars.
Free participation is possible for members of AFPT - Club Phase 1 (Association Française de Pharmacologie Translationnelle). If you are not a member yet, you can go to the website of AFPT - Club Phase 1 and join as a member (using the membership form) before subscribing to this webinar for free.
Non-members pay 30 € to participate to this webinar.
Please note access to the webinar is only possible after either having paid your membership at AFPT-Club Phase 1 (and participating to the webinar for free) or having registered as a non-member, paying 30 € to participate after having received the invoice.